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Abstract
Background: Boiled aqueous extract of flowers (AEF) from Nyctanthes arbor-tristis L. are used in Sri Lankan traditional
Ayruvedic Medicine to manage diabetes mellitus. AEF has widely been used as a folk medicine for the treatment of
various ailments due to its therapeutic activity. However, little is known concerning therapeutic activity of the extract
as well as its underline mechanisms and safety. Diabetes is known to increase low-density cholesterol and decrease
high-density cholesterol thus triggering coronary diseases. Hence, the primary objective of the present study is to
investigate the hypoglycemic and hypolipidemic activities of the AEF.
Methods: AEF was prepared and male mice (n = 9 group) were gavaged either with 250, 500 and 750 mg/kg of AEF or
distilled water (DW). Subsequently, fasting and random blood glucose concentrations were determined. To investigate
mechanisms of actions of AEF, animals were orally administered with 500 mg/kg or the vehicle (DW) and glucose
tolerance was performed before and after glucose challenge. For further studies, in vitro alpha-amylase assay and
glucose absorption from the gastrointestinal tract were performed using 500 mg/kg of the extract. Additionally,
glycogen content in the liver and skeletal muscles, a complete lipid profile assay, and toxicological and biochemical
parameters were conducted after a chronic study.
Results: Five hundred mg/kg and 750 mg/kg of AEF significantly (p < 0.01) reduced fasting blood glucose levels
respectively by 49 and 39 % at 4 h post-treatment, while 500 mg/kg of AEF also decreased the random blood glucose
level significantly (p <0.01) by 32 % at 4 h post-treatment. AEF significantly inhibited glucose absorption by 85 % from
the intestine and increased diaphragm uptake of glucose by 64 %. The extract also exhibited inhibition (16.66 %) of
alpha-amylase enzyme activity. It also decreased the level of total cholesterol (by 44.8 %), triglyceride (by 53 %) and
increased (by 57 %) the high-density lipoprotein cholesterol. Treatment with AEF did not induce any overt signs of
toxicity or hepatotoxicity.
Conclusion: Results the present study indicated that AEF possess hypoglycemic and hypolipdemic properties.
Therefore, AEF could be used as an alternative medicine in management of diabetes mellitus.
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Background
Diabetes mellitus is a major global burden with 382
million people suffering from the disease at the end of
2013 and is projected to increase up to 592 million by
2035 [1]. More than 80 % of the diabetes deaths occur in
the low and middle-income countries and more than 471
billion US dollars are spent in the health care expenditure
worldwide for diabetes [2]. Type 1 diabetes is prevalent
among Northern European countries while Type 2
diabetes is prevalent in African and South Asian countries
[3]. Sri Lanka, being a South Asian country, type 2 diabetes
is prevalent. Type 2 diabetes is also known as non-insulin-
dependent diabetes and is caused by the body’s ineffective
use of insulin [4]. One in five adult in Sri Lanka is suffering
either from diabetes or pre-diabetes [5]. The American
Diabetes Association defines a pre-diabetic individual as
an individual with blood glucose levels higher than normal
(impaired fasting glucose between 100 and 125 mg/dl,
impaired glucose tolerance between 140 and 199 mg/dl,
and HbA1c between 5.7 and 6.4 %) but not high enough
to be considered diabetic (impaired fasting glucose
between >126 mg/dl, impaired glucose tolerance between
>200 mg/dl, and HbA1c between >6.5 % [1]. Diabetes
tends to increase low-density lipoprotein cholesterol and
decrease high-density lipoprotein cholesterol levels in
serum triggering coronary occlusions and blocks. Therefore,
it is important to control not only blood glucose levels but
also blood lipid levels. It has been shown that current
treatment for diabetes with synthetic hypoglycemic agents
can cause adverse effects including hypoglycemia, gastro-
intestinal disturbances, renal toxicity and hepatotoxicity [6].
Hence, search of plant formulations with minimum toxicity
remains a challenge. Various plant species have been known
to possess potent hypoglycemic activity. Therefore, plant
remedies have been used as an alternative treatment for
diabetes mellitus in Ayurvedic and traditional medicine by
different cultures around the world [7].
Nyctanthes arbor-tristis (Family-Oleaceae), commonly
known as night-flowering Jasmine or Sepalika (in Sinhala)
distributed in tropical and sub-tropical regions of Sri
Lanka. It is one of the well-known medicinal plants for its
antidiabetic properties [8]. It is a large shrub growing into
about 10 m tall with a flaky grey bark. Flowers are fragrant
and have a 5–8 lobes, white corolla with an orange center
[9, 10]. Different parts of N. arbor-tristis plants are used in
Ayurveda, Siddha-Ayurveda and Unani systems of medi-
cine as a digestives, antidote to reptile venoms, mild bitter
tonic, laxative, diaphoretic, diuretic and arthritis [11]. The
leaves extract has many proved pharmacological effects
like anti-bacterial [10], analgesic, anti-inflammatory [11],
anti-diabetic [8, 12], anti-arthritic [13], antioxidant [10],
hepatoprotective [14] and antispasmodic activities [12].
Flower extract is also used as a stomachic, carminative,
astringent to bowel, antibilious, expectorant, hair tonic
and in the treatment of piles and various skin diseases
[7]. Boiled aqueous extract of flowers are known to
have sedative effects [12], while fresh flowers and dried
leaves of N. arbor-tristis extract demonstrated antispas-
modic activity, antihelmintic activity, while stem bark ex-
tracts exhibit anti-diabetic activity and anti-inflammatory
activity [9].
It has been shown that chloroform extracted N. arbor-
tristis flowers reduce blood glucose level in diabetic
induced rats [14]. In traditional Sri Lankan Ayurveda
medicine; boiled aqueous extract of N. arbor-tristis
flowers had been used in the management of type 2
diabetes mellitus [14]. But thus far, this is not scientific-
ally proven and the mechanisms by which N. arbor-
tristis can reduce diabetes have not been established.
Analyzing its antidiabetic and antilipidemic potentials
could generate baseline data for development of a new
therapy with minimum toxicity and high efficacy. Thus, the
present study was conducted to investigate hypoglycemic
and hypolipidemic roles of AEF from N. arbor-tristis in
male mice. Further, we extended the investigation to study
underling toxic effects of AEF.
Methods
Plant material
Fresh N. arbor-tristis flowers were collected early morning
(6.00–7.00 a.m.) from home gardens of Bentota (6.4200°
N, 80.0000° E), Sri Lanka between February and April
2013 and was identified and authenticated by Prof. B.M.P
Singhakumara, Dept. of Forestry and Environment
Science, University of Sri Jayewardenepura. A voucher
specimen (SP no: DP/01) was deposited in the Depart-
ment of Zoology, University of Sri Jayewardenepura.
Method of extraction
Collected flowers were thoroughly washed with water
and dried in shade at room temperature. Dried flower
materials were milled to fine powder using a mechanical
grinder and 2 g of powder was infused in 100 ml of
boiling water for 30 min. Brown colour AEF was obtained
and filtered using a muslin cloth (yield 21.42 % W/V).
Animals
Healthy, adult ICR (Imprinting Control Region) male mice
(weight 30–40 g) were used for all experiments. They were
maintained under standard animal house conditions
(temperature: 26–30 °C, photoperiod: approximately 12 h
natural light per day and relative humidity: 55–60 %) with
continuous access to pelleted food (Vet House Ltd,
Colombo, Sri Lanka) and tap water. Research was con-
ducted in accordance with the internationally accepted
principles for care and use of laboratory animals and guide-
lines. Ethical approval (ethical clearance no.711/13) was
obtained by the institutional ethical review committee
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(Ethical Review Comittee, Faculty of Medicine, University
of Sri Jayewardenepura).
Dosages & treatment
Doses of 250 mg/kg, 500 mg/kg and 750 mg/kg of AEF
were prepared directly from the hot infusion. The mid
dose or 500 mg/kg of AEF was selected based on dose
recommended by traditional Ayruvedic physicians of Sri
Lanka in prescribing herbal decoctions. To evaluate
fasting blood glucose level, 36 male mice were randomly
divided into 4 groups (n = 9/group) and treated either with
1 ml of DW or 250 mg/kg, 500 mg/kg and 750 mg/kg of
AEF. Since the maximum glucose reduction was observed
with animals treated with 500 mg/kg, this dose was used
for further experiments. Hence, only 18 mice were used
for each experiment with 9 mice per group.
Effects of AEF on fasting & random blood glucose levels
After an overnight fast for 16 h with free access to water
mice were treated either with 3 doses of AEF or DW.
Using aseptic conditions, blood samples were collected
from animals to determine blood glucose levels at 1 h
prior to the treatment and 2 h, 4 h post-treatment. Aver-
age blood glucose value was taken after triplicate mea-
surement [15]. To evaluate the random blood glucose
level, animals were gavaged only with 500 mg/kg AEF
and DW and same procedure was used without fasting
the animals [16].
Effects of AEF on glucose tolerance
Method previously described by Okaine et al. [17] was
used. After an overnight fast of mice for 16 h, animals
were assigned randomly into 2 groups (n = 9). They were
orally administerd either with DW or 500 mg/kg of AEF
and 30 min after gavaging, all mice were loaded with
2 g/kg glucose solution. Blood samples were collected
and glucose levels 1 h prior to treatment and 2 h, 4 h
after glucose challenge were determined.
Effects of AEF on gastrointestinal glucose absorption
Two groups of mice were orally administrated either
with 500 mg/kg of AEF or DW and after 30 min, mice
were treated orally with 10 ml/Kg of 50 % glucose. Two
hours following the treatment, mice were sacrificed and
glucose absorption by the intestine was determined [14].
Effects of the AEF on liver & skeletal muscle glycogen
content
Two sets of mice (n = 9) were treated orally either with
1 ml of DW or 1 ml of 500 mg/Kg AEF for 30 consecu-
tive days. All the mice were sacrificed and portions of
their livers and gastrocnemius muscles were removed
for glycogen analysis [18].
Effects of AEF on diaphragm uptake
Eighteen mice were randomly divided in to 2 groups
(n = 9) and were treated either with the plant extract or
DW for 30 days. Animals were sacrificed on day 31 and
isolated diaphragms incubated in 1 g/l glucose solution
to assess glucose uptake [19]. Glucose concentrations
was measured immediately prior to incubation and
30 min following incubation.
Effects of the extract on α-Amylase assay in vitro
The α-amylase inhibition assay for the AEF was performed
according to the methods described by Rahimzadeh et al.
[20] with slight modifications. Briefly, the assay mixture
consisted of 500 μl of 1 % starch solution, 400 μl of 0.1 M
sodium phosphate buffer (pH 7.0), 50 μl of plant extract
dissolved in dimethyl sulfoxide (DMSO) and 50 μl of
pancreatic α-amylase (Sigma, St. Lous, USA) solutions
(2 U/ml). Then, the reaction medium was incubated at
37 °C for 10 min followed by addition of 3 ml of 3,5-
dinitrosalicylic acid (DNS) color reagent. Finally, the
solution was placed in a boiling water bath for 5 min,
diluted with 20 ml of distilled water and the absorbance
was measured at 540 nm. Absorbance of a control sam-
ple was prepared accordingly without plant extract and
acted as negative control. The standard antihyperglycemic
agent acarbose was used as positive control. The experimen-
tal extract and acarbose were tested with varying concentra-
tions from 1.25 to 5 mg/ml. The results were expressed as
percentage inhibition using the following formula:
Inhibition %ð Þ ¼ Ac−As½  X 100
Ac
where Ac is the absorbance of the control reaction without
sample and As is the absorbance of the sample. IC50 value,
defined as the sample concentration (mg/ml) at which 50
% inhibition of the enzyme activity occurs, was calculated
from the graph plotting enzyme inhibition against sample
concentration. All tests were carried out for three sample
replications and the results were averaged.
Effects on serum lipid profile
Blood samples from 2 groups of mice (n = 9) were centri-
fuged at 4000 rpm for 20 min to separate serum to deter-
mine total cholesterol (TCH), high-density lipoprotein
cholesterol (HDL-CH), low-density lipoprotein cholesterol
(LDL-CH), and triglycerides (TG) using UV spectropho-
tometer (Labomed, INC, Los Angeles, USA) method [21].
Toxicological and biochemical parameters
Two groups of mice were orally treated (between
9.00 a.m. and 10.00 a.m.) either with 1 ml of 500 mg/kg of
AEF or 1 ml of DW for 30 consecutive days. Animals were
observed daily between 11.00 a.m. and 12 noon for any
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overt sign of toxicity (diarrhoea, salivation, lachrymation,
tremors, ataxia, loss of fur, change of fur colour, postural
abnormalities or behavioural changes), stress (fur erection
and exophthalmia), aversive behaviours, during the treat-
ment period. Percentage of body weight gain, and food
and water intake was determined during the study period.
Upon autopsy of animals, blood was collected from
heart puncture to tubes containing heparin. Plasma was
separated and alanine aminotransferase (ALT) and aspar-
tate aminotransferase (AST) concentration were deter-
mined [22]. Subsequently, liver, kidney, spleen, heart and
testes were removed from each mouse. Organs were blot-
ted free of blood and wet weights were recorded. The
organ weights were expressed as percentage of the organ
weight per 1 g of body weight. Parts of liver and kidney
were fixed in Bouin’s fixatives for histopathological ana-
lysis. After routine processing, paraffin sections of 4 μm
thick sections were cut and stained with haematoxylin
and eosin for microscopic examination.
Statistical analysis
Statistical analysis was carried out using parametric one-
way analysis of variance (ANOVA) followed by Mann–
Whitney U-test using the statistical package, Minitab 14
for windows. The data were expressed as mean ± Standard
Error Mean (SEM). The p value was set to ≤ 0.05.
Results
Effects on fasting & random blood glucose levels
Mice treated with 250 mg/kg of AEF had no effect on
blood glucose level during the experimental time period.
But, 500 and 750 mg/kg of plant extract showed significant
(p < 0.01) blood glucose decreasing efficacy at 4 h post-
treatment. The blood glucose levels were reduced respect-
ively by 49 and 39 % when compared to control. The AEF
failed to inhibit fasting blood glucose level at 1 h or 3 h
and hence a delayed effect is evident (Fig. 1). Figure 2
shows the dose dependent fasting blood glucose activity of
AEF and linear regression analysis showed that the effect
was not dose-dependent (R2 = 0.546).
Treatment with effective dose (500 mg/kg) of AEF of N.
arbor-tristis significantly (p < 0.01) reduced the random
blood glucose level of mice by 32 % at 4 h thus indicating
a delayed glucose-inhibiting efficacy (Fig. 3).
Effects of AEF on glucose tolerance test
As shown in Table 1, the initial fasting blood glucose
levels of both groups did not show any apparent dif-
ference. Similarly, treatment of mice with 500 mg/kg of
AEF did not alter the fasting blood glucose level at 2 and
4 h following oral glucose challenge compared to control.
Effect of AEF on diaphragm and gastrointestinal
glucose uptake
AEF produced a significant (p < 0.05) increase in dia-
phragm uptake of glucose compared to control. Similarly,
AEF significantly (p < 0.05) inhibited glucose absorption
by 83 % from the intestinal lumen 2 hours following treat-
ment compared to control (Table 2).
Effects of AEF on liver and skeletal muscle glycogen
content
Within group analysis revealed that AEF treated animals
did not show significant alteration in liver or skeletal
Fig. 1 Effects of aqueous extreact of N. arbor-tristis flowers or control (DW) on fasting blood glucose levels of normal mice. Mice treated either
with AFE of N. arbor-tristis at 250 mg/kg (□), 500 mg/kg (Δ), 750 mg/kg (□) or DW (–). Glucose concentration (mg/dl) were measured prior to
treatment and 1 h, 4 h post-treatment. Results are expressed as mean ± SEM; **P < 0.01
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muscle glycogen content when compared to their re-
spective controls. The results are depicted in Table 2.
Effects of AFE on in vitro α-Amylase assay
AFE produced a dose response inhibition of in vitro α-
amylase activities. Alpha-amylase activity was sig-
nificantly inhibited by 16.67 and 33.33 % respectively at
500 mg/kg (p < 0.05) and 750 mg/kg (p < 0.01) AEF
(Table 3).
Effects of AEF on serum lipid profile
Table 4 shows the serum levels of TCH, TG, LDL-CH
and HDL-CH in normal and experimental animals of
each group. A significant (p < 0.01) reduction in TCH
and TG (by 44.88 and 53 % respectively) were evident in
the treated group when compared to the control mice.
Similarly, AEF significantly (p < 0.05) increased serum
HDL-CH level by 57.27 % but did not exert any effect
on serum LDL-CH levels.
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Fig. 2 Linear regression analysis of N. arbor-tristis or distilled water on fasting blood glucose levels of mice. Mice were treated once either with
250 mg/kg, 500 mg/kg and 700 mg/kg of AFE or DW. Fasting blood glucose level was measured prior to treatment and 2 h, 4 h post-treatment.
Results are expressed as mean ± SEM. (R2 = 0.546)
Fig. 3 Effects of N. arbor-tristis or DW on random blood glucose levels of mice. Mice were treated once either with 1 ml of 500 mg/kg of AFE or
distilled water. Random glucose level was measured prior to treatment and 2 h, 4 h post-treatment. Results are expressed as mean ± SEM. **P < 0.01
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Effects of AEF on biochemical and toxicological
parameters
Oral ingestion of the extract did not alter serum ALT (con-
trol: 2.968 ± 0.654 versus treatment: 2.476 ± 0.420 IU/L)
or AST (control: 12.618 ± 0.438 versus treatment:
12.569 ± 0.325 IU/L) levels (Table 4). Mice treated for
30 days with 500 mg/kg AEF did not show any overt
signs of clinical toxicity, stress and aversive behav-
iours during the treatment period. Further, no deaths
were observed. There was no suppression of body
weight, water or food intake (Table 5) and organ
weighst (Table 4) observed during the treatment period.
Histopathological analysis of the liver and kidney portions
after treatment with AEF did not exhibit any obvious
effect when compared to control.
Discussion
Morbidity and mortality due to diabetes is increasing
worldwide and is the third cause of death after cancer
[23]. Remedies available today for management of
diabetes can lead to potential adverse effects. Therefore,
plant derived components devoid of adverse effects have
attracted particular attention as an alternative source to
battle against diabetes. Thus, in lieu of searching of
natural therapy, hypoglyceamic and hypolipidemic ef-
fects of AEF of N. arbor-tristis have been evaluated in
the present study.
This study revealed that AEF of N. arbor-tristis pos-
sesses both hypoglycemic and hypolipidemic activities.
In the current experiment, 500 mg/kg dose was equiva-
lent to dosage prescribed by traditional Ayruvedic doc-
tors in Sri Lanka and therefore, this dose was used as the
mid dose to report hypoglycemic activity of the extract.
The results indicate that AEF produced significant re-
duction of blood glucose levels 4 h after oral administra-
tion in mice kept fasting overnight at doses of 750 and
500 mg/kg. Typically, traditional doctors advice patients
to partake decoctions early in the morning and findings
of this study align with their practice. It was observed
that AEF exerted its hypoglycemic effects through none
dose-dependant manner with the mid dose producing
pronounced hypoglycaemic effect. Further, the extract
did produce a delayed hypoglycemic effect after 4 h and
such delayed activity had been reported previously in
plants such as Kokoona zeylanica L. [24], Strychnos
henningsii L. [25] and Phylanthus debilis L. [26]. High
dose of the extract exhibiting less hypoglycemic activity
than the mid dose may be due to receptor down regula-
tion activity of the drug thus decreasing the number of
receptors for a drug or presence of other phytochemical
substances [27]. Further, it has been reported that pres-
ence of hypoglycemic and/or antagonistic substances in
the extract may diminish hypoglyceamic effect [28].
Sireesha et al. [29] reported that higher doses of plant
extract may posses various constituents that could result
in non-specific increasing and reduction of blood glu-
cose levels thus resulting in net effect of increasing
blood glucose levels. But, future investigations are re-
quired to clarify delayed hypoglycemic effects produced
by AEF.
Hypoglycemia may occur due to glucose oxidation via
increase of metabolic actions as a result of high food
consumption. Daily monitoring food intake of animals
over one month period indicated that food intake was
more or less similar in both control and treated groups.
Hence, hypoglycemic activity observed during this study
may not be due to low intake of carbohydrate diet [30].
Further, AEF did not increase the glucose tolerance after
oral glucose challenge, which indicates that hypogly-
cemic activity exhibited by N. arbor-tristis may not to be
due to insulin mimicacy action [31]. Previous qualitative
Table 1 Effect of N. arbor-tristis aqueous extract of flower on oral
glucose tolerance test in mice. Glucose concentration (mg/dl)
Treatment Pre-treatment Post treatment
1 h 3 h 5 h
Control 113.5 ± 14.4 168.2 ± 24.3 87.13 ± 1.91 82.11 ± 3.77
AEF 86.87 ± 6.75 155.5 ± 13.9 91.03 ± 6.90 138.4 ± 12.2
Values are expressed as mean ± SEM, n = 9. Control groups received distilled
water and treatment group received 500 mg/kg of the extract. No significant
difference was observed between the groups. The data was analyzed by
parametric method-ANOVA
Table 2 Effect of aqueous flower extract from N. arbor-tristis
on gastrointestinal and diaphragm glucose uptake, liver and
skeletal muscle glycogen content in mice
Parameters Control Treatment
Gastrointestinal absorption of glucose (mg/dl) 18.95 ± 2.85 132.3 ± 16.1*
Diaphragm uptake of glucose (mg/dl) 204.5 ± 66.1 578 ± 83.4*
Glycogen content in the liver (mg/dl) 2.238 ± 0.247 2.643 ± 0.284
Glycogen content in skeletal muscle (mg/dl) 0.523 ± 0.091 0.419 ± 0.076
The data are given as mean ± S.EM (n = 9). Values are statistically significant
at *p < 0.05. Control group was given distilled water while test group was
given 500 mg/kg of the extract. To measure diaphragm glucose uptake, and
glycogen content in liver and skeletal muscles, mice were treated for 30 days.
For measurement of intestinal glucose absorption, mice were treated with
acute doses. The data was analyzed by parametric method-ANOVA
Table 3 In vitro α-amylase inhibitory effect of aqueous flower
extract from N. arbor-tristis




Values are statistically significant at *p < 0.05, **p<0.01. Control group was
treated with distilled water while test groups were treated with 250, 500 &
750 mg/kg of the extract. To measure diaphragm glucose uptake, and
glycogen content in liver and skeletal muscles, mice were treated for 30 days.
For measurement of intestinal glucose absorption, mice were treated with
acute doses. The data was analyzed by parametric method-ANOVA
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phytochemical screening of N. arbor-tristis flowers ex-
hibited the presence of abundant amount of manitol; a
modified diterpenoid nycanthin, flavonoids, anthocyanins,
nyctanthin, d-mannitol, tannin and glucose, carotenoid,
glycosides viz 6β-hydroxylonganin and β-sitosterole posses
hypoglycemic activity [32]. Therefore, hypoglycemic ac-
tivity observed in the present study can be attributed to
presence of flavonoids iridoide 6β-hydroxylonganin in N.
arbor-tristis flowers [33].
The AEF had a gummy viscous appearance, which
suggested presence of fiber [34]. In vitro studies had
confirmed that glucose binds to dietary fibers even at
very low glucose concentrations and these bound glu-
cose are incapable of binding to specific transport pro-
tein for transportation. Thus, inhibiting glucose uptake
from the gastrointestinal tract [35]. In addition, inhi-
bition of intestinal glucose absorption may also be due
to impaired intestinal Na+- glucose co-transporter as re-
ported with synthetic phlorizin derivatives [36]. The esti-
mation of glucose in mouse diaphragm is a commonly
employed reliable method to study peripheral uptake of
glucose. AEF also exhibited marked enhancement of
glucose uptake by the diaphragm and was found to be
more effective than insulin. It appears that AEF has dir-
ect peripheral action [37]. It has been also been suggested
that direct glucose uptake by peripheral tissues is via
receptor up regulation [38]. Therefore, increase glucose
uptake by diaphragm can be attributed that long-term
treatment of AEF that can lead to receptor up regulation.
AEF inhibited α- amylase activity in mice plasma in
vitro. Inhibition of α- amylase activity can be attributed to
several factors such as fiber concentration, presence of
inhibitory constitutions and ecapsulation of starch and
enzyme by fibers present in AEF [39]. Hence, hypoglycemic
property of AEF can be linked with ability of the tannins
and flavonoids reported in the flower extract to inhibit α-
amylase enzyme. One possible mechanism of the extract to
induce hypoglycemia could be via provoking inhibition of
α- amylase activity [40]. This suggests that, it is possible for
AEF to breakdown α linkage of polysaccharide to retard
digestion and absorption of carbohydrates in the small
intestine, thus reducing the increasing of blood glucose
levels [35]. This hypothesis can further be supported by in-
hibition of glucose uptake observed in the gut with AEF
treated animals. Thus, blood glucose reducing effects of
AEF can be attributed to inhibition of intestinal glucose
absorption or sensitivity of insulin in peripheral tissues
or α- amylase inhibitory activity or combination of these
mechanisms.
In diabetic condition hypertriglyceridemia and hyper-
cholestermia are the common factors involved in the
development of the atherosclerosis and coronary heart
disease. In diabetes, increased levels of TCH are one of the
major factors for coronary heart disease (hyperlipidaemia)
and its incidence of atherosclerosis [41]. Interestingly, AEF
reduced both serum TCH and TG levels and increased
HDL-CH Level. The more prominent effect is the reduc-
tion in LDL-CH, which is a known triggering factor for
coronary occlusion or its block. HDL-CH is protective
cholesterol and is responsible for transportation of choles-
terol [42]. Considering AEF’s effect on these lipid compo-
nents, it can be assumed a potential hypolipidemic agent,
which will be a great advantage both in diabetic condition
as well as the associated atherosclerosis or hyperlipidemic
conditions. Flavonoids from AEF [43] may augment acti-
vity of lecithin acyl transferase, which regulates blood
lipids by incorporation of free cholesterol into HDL-CH
thus increasing HDL-CH [41]. Similarly, saponin found in
N. arbor-tristis [44] can find its way to cholesterol in intes-
tinal lumen thus impairing cholesterol absorption from
the intestine or bile acid causing reduction in extra hepatic
circulation and increasing metabolism of cholesterol to
sterol thorough their fecal excretion. Increase bile acid ex-
cretion offset by enhanced synthesis from cholesterol from
the liver consequently lowers the plasma cholesterol [27].
Sub-chronic oral administration of mid dose of AEF did
not show any overt sign of clinical toxicity, stress and
aversive behaviours, hepatotoxicity (ALT and AST levels,
liver weight and histopathology) or renootoxicity (kidney
weight and histopathology). It has been established that
liver is the main organ where toxic compounds are detoxi-
fied. Liver damage and it’s recovery is usually assessed by
measuring serum ALT and AST levels. In the present no
Table 4 Effects of aqueous flower extract from N. arbor-tristis on
lipid profile parameters, biochemical parameters and organ
weights of mice after 30 days of treatment
Parameters Control Treatment
Lipid profile parameters
Total Cholesterol (mg/dl) 127.9 ± 16.5 100.8 ± 11.5**
Triglycerides (mg/dl) 79.46 ± 7.46 37.32 ± 7.85*
HDL-CH (mg/dl) 43.073 ± 22.7 100.8 ± 25.2*
LDL-CH (mg/dl 29.73 ± 5.84 27.3 ± 10.8
Biochemical parameters
ALT (IU/l) 2.968 ± 0.654 2.476 ± 0.42
AST (IU/l) 12.618 ± 0.438 12.569 ± 0.325
Organ weights
Liver (g) 2.2343 ± 0.0993 2.1950 ± 0.0687
Spleen (g) 2.2288 ± 0.0177 2.2538 ± 0.0207
Kidney (g) 0.7100 ± 0.0316 0.2350 ± 0.0325
Testes (g) 0.2571 ± 0.0194 0.6475 ± 0.0177
The data are given as mean ± S.EM (n = 9). Values are statistically significant at
*p < 0.05, **p < 0.01. Control group was given distilled water while treated
group was given 500 mg/kg of the extract. AEF: aqueous extract of flowers.
HDL-CH: High density lipoprotein cholesterol, LDL-CH – Low density
lipoprotein cholesterol, ALT: Alanin aminotransferase levels; AST: serum Aspartate
aminotransferase. The data was analyzed by parametric method-ANOVA
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comparable changed in the treated mice were detected
indicating no hepatotoxicity. These findings were further
confirmed by the histopathological examination on the
liver, which revealed to be normal. Further there was no
change in body weight, food and water intake during the
study period, thus indicating that boiled aqueous extract
of Nyctanthes flowers are safe oral herbal drug.
Present study demonstrated that AEF could exert
hypoglycemic and hypolipidemic activities with mini-
mum toxicity. The mechanisms for the hypoglycemic
action of N. arbor-tristis flowers could be via inhibiting
α-amylase, inhibiting glucose diffusion by adsorbing and
trapping glucose in its fiber matrix and by increasing
glucose transport across the cell membranes. It may
support the claims made on folkloric uses of AEF of N.
arbor-tristis in the treatment of diabetes mellitus in
traditional Sri Lankan Ayurveda medicine. This study
can be further extended to revel hyperglycemic effects
with diabetic mouse model.
Conclusion
From this study, we can conclusively state that AEF of
N. arbor-tristis possesses hypoglycemic and beneficial
hypolipidemic properties. Finally, it can be considered
that AFE is safe for oral consumption and elicits
promising hypoglycemic activity in animal experiments.
However the nature of the active principle(s) responsible
for all these positive effects requires further investigation.
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